Part 1 I have to answer this question with scholary cited sources
Describe the clinical aspects of generalized anxiety disorders. How are anxiety disorders treated?
Part 2 I have to reply to my class mates topic with scholarly cited sources. 1 paragraph each.
7 hours ago, at 10:38 PM
Anxiety is worry about every day events that will happen. It can be also when a person has been in a domestic violence situation where they already know what is going to happen when they see the abuser act a certain way. Individuals that suffer from anxiety they worry about money, health, events that are going to happen and they already expect a disaster as a result. According to Butcher, Hooley, & Mineka, (2014). “n contrast to fear and panic, the anxiety response pattern is a complex blend of unpleasant emotions and cognitions that is both more oriented to the future and much more diffuse than fear (Barlow, 1988, 2002). But like fear, it has not only cognitive/subjective components but also physiological and behavioral components. At the cognitive/subjective level, anxiety involves negative mood, worry about possible future threats or danger, self-preoccupation, and a sense of being unable to predict the future threat or to control it if it occurs.” (pg. 165).
Anxiety disorders are treated with psychotherapy, medication and self-help techniques, they can get a yoga, or meditation classes to help relief the anxiety at the time, also breathing techniques can help.
Butcher, J. N., Hooley, J. M., & Mineka, S. (2014). Abnormal Psychology. (16th ed.). Boston, MA: Pearson.
3/2/20, 5:06 PM
Anxiety disorders are among the most common psychiatric illnesses, with generalized anxiety disorder (GAD) being one of the most common in primary care. Lifetime prevalence of GAD has been estimated to be two percent to three percent in the parts of Europe and near six percent in the United States. GAD is a chronic disorder characterized mainly by pathological worry, which presents with a variety of somatic and psychological symptoms. It was found that GAD has a great impact on health-related quality of life, and especially on sleep. It has also been found to have an impact on patient functionality, causing substantial disability. The pharmacological management of GAD is centered mainly on anxiolytic drugs (i.e., benzodiazepines), either in monotherapy or in combination. However, benzodiazepines have limited efficacy in relieving comorbid depressive symptoms and have undesirable effects, and the general guidance is that benzodiazepines should be restricted to short-term use. Despite this, usual care (UC) practice including these drugs is still widespread. As they are recommended, effective treatments that may be used on a long-term basis include selective-serotonin reuptake inhibitors (SSRIs) and selective serotonin-norepinephrine reuptake inhibitors (SNRIs), and many patients with GAD are receiving such medicines on a daily basis, either as monotherapy or as an add-on treatment.
Miguel A Ruiz1 Enrique Álvarez2 Jose L Carrasco3 José M Olivares4 María Pérez5 Javier Rejas6 1 Department of Methodology, School of Psychology, Universidad Autónoma de Madrid, Madrid, 2 Department of Psychiatry, Hospital de la Santa Creu i San Pau, Barcelona, 3 Department of Psychiatry, Hospital Clínico San Carlos, Madrid, 4 Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario, Vigo, 5 Medical Department, Pfizer, S.L.U., Alcobendas, Madrid, 6 Health Economics and Outcomes Research Department, Pfizer, S.L.U., Alcobendas, Madrid, Spain Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice